UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000002042
Receipt number R000002493
Scientific Title Phase II trial of mFOLFOX6/XELOX plus bevacizumab with oxaliplatin in a stop and go fashion in advanced metastatic colorectal cancer
Date of disclosure of the study information 2009/06/05
Last modified on 2018/06/12 12:20:35

No. Disposal Last modified on Item of update
1 Insert 2009/06/04 08:24:01
2 Update 2009/06/04 10:31:10 Public title
3 Update 2009/06/04 10:33:39 Interventions/Control_1
Key inclusion criteria
4 Update 2009/06/04 10:51:26 Key exclusion criteria
5 Update 2009/06/04 11:01:43 Key exclusion criteria
6 Update 2009/06/05 18:27:30 TEL
Organization1
Tel1
Email1
7 Update 2009/12/25 12:25:50 Recruitment status
8 Update 2010/10/26 10:25:32 Public title
9 Update 2010/10/26 10:33:25 Key inclusion criteria
10 Update 2010/10/26 10:38:50 Division name
Address
11 Update 2010/10/26 10:58:08 Interventions/Control_1
Interventions/Control_1
12 Update 2010/11/10 18:04:42 Public title
13 Update 2010/11/10 18:06:08 Narrative objectives1
14 Update 2011/11/29 23:16:03 Post marketing survey by drug manufacture etc., specified by Japanese law.
15 Update 2012/02/08 19:47:46 Recruitment status
16 Update 2012/02/08 19:52:34 Date analysis concluded
17 Update 2013/01/10 16:10:04 Email1
18 Update 2017/06/12 08:48:00 Email
Name of primary person or sponsor
Organization
19 Update 2017/06/12 08:50:10 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
20 Update 2017/06/12 08:51:56 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
21 Update 2018/06/12 12:20:35 Recruitment status
Publication of results